Q4 2016 13F Holders as of 12/31/2016
-
Type / Class
-
Equity / Common Stock, $0.01 par value
-
Shares outstanding
-
101M
-
Number of holders
-
134
-
Total 13F shares, excl. options
-
30.1M
-
Shares change
-
+44.1K
-
Total reported value, excl. options
-
$645M
-
Value change
-
+$2.9M
-
Put/Call ratio
-
1.91
-
Number of buys
-
68
-
Number of sells
-
-46
-
Price
-
$21.40
Significant Holders of FIBROGEN INC - Common Stock, $0.01 par value (FGEN) as of Q4 2016
153 filings reported holding FGEN - FIBROGEN INC - Common Stock, $0.01 par value as of Q4 2016.
FIBROGEN INC - Common Stock, $0.01 par value (FGEN) has 134 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 30.1M shares
of 101M outstanding shares and own 29.85% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (4.65M shares), BlackRock Fund Advisors (2.44M shares), BlackRock Institutional Trust Company, N.A. (1.55M shares), FMR LLC (1.53M shares), STATE STREET CORP (1.36M shares), JANUS CAPITAL MANAGEMENT LLC (1.35M shares), JPMORGAN CHASE & CO (1.06M shares), Hillhouse Capital Management, Ltd. (1M shares), PRICE T ROWE ASSOCIATES INC /MD/ (852K shares), and PointState Capital LP (827K shares).
This table shows the top 134 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.